Skip to content
Screener

Acadia Pharmaceuticals ACAD Q1 2026 earnings

Reported May 6, 2026 · After market close

Revenue$268.1MMiss by $12.2M
EPS$0.02Miss by $0.02
Revenue estimate$280.3M
EPS estimate$0.04

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$332.3M
EPS estimate$0.21

Financials

Q1 2026

Income statement

See full
Revenue$268.1M+9.7%
Gross profit$243.3M+8.6%
Operating income-$4.6M-124%
Net income$3.6M-80.8%
EPS (diluted)$0.02-81.8%

Balance sheet

See full
Cash & equivalents$282.2M+29.6%
Total debt$50.8M-9.3%
Total equity$1.2B+63.1%
Total assets$1.6B+41.8%

Cash flow

See full
Operating cash flow$34.0M+67.2%
CapEx$5.2M—
Free cash flow$28.8M+41.6%

Valuation & ratios

Valuation

as of 03/31/26
See full
Market cap$3.8B+37.0%
Enterprise value$3.56B+36.6%
P/E10.1×-2.0×
P/S3.5×+0.7×

Profitability

See full
Gross margin91.5%-0.6pp
Operating margin7.4%-16.2pp
Net margin34.3%+11.3pp

Returns & leverage

See full
Return on equity37.3%+0.1pp
Debt / equity0×0.0×
Current ratio3.6×+0.7×

Segments

By product

See full
Nuplazid$166.9M+4.5%
Daybue$101.1M+19.6%

By segment

See full
Reportable Segment Aggregation Before Other Operating$268.1M+9.7%

FAQ

When did Acadia Pharmaceuticals report Q1 2026 earnings?
Acadia Pharmaceuticals (ACAD) reported Q1 2026 earnings on May 6, 2026 after market close.
What were Acadia Pharmaceuticals's Q1 2026 revenue and EPS?
Acadia Pharmaceuticals reported revenue of $268.1M and eps of $0.02 for Q1 2026.
Did Acadia Pharmaceuticals beat estimates in Q1 2026?
Revenue missed the consensus estimate of $280.3M by $12.2M. EPS missed the consensus estimate of $0.04 by $0.02.
How did Acadia Pharmaceuticals's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 9.7% from $244.3M a year earlier and eps declined 81.8% from $0.11.
Where can I find Acadia Pharmaceuticals's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-209253) and the 10-Q periodic report (0001193125-26-209731) directly on SEC EDGAR. The filing index links above go to sec.gov.